✦ LIBER ✦

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

✍ Scribed by Rao, S; Cunningham, D; Hawkins, R E; Hill, M E; Smith, D; Daniel, F; Ross, P J; Oates, J; Norman, A R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

44 Phase III trial comparing epirubicin,

✍ S. Rao; D. Cunningham; R. Hawkins; M.E. Hill; D. Smith; F. Daniel; P.J. Ross; J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

A prospective randomized phase III trial

✍ Kim, T.W.; Choi, S.J.; Ahn, J.H.; Bang, H.S.; Chang, H.M.; Kang, Y.K.; Lee, J.S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

PCN37 PRELIMINARY COST-CONSEQUENCE ANALY

✍ AM Horgan; J Knox; G Liu; PA Bradbury; C Sahi; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

A randomised phase III trial of adjuvant

✍ H.P. Kalofonos; A. Bamias; A. Koutras; P. Papakostas; G. Basdanis; E. Samantas; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Phase I study of epirubicin, cisplatin a

✍ Rao, S; Starling, N; Cunningham, D; Benson, M; Wotherspoon, A; Lüpfert, C; Kurek 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

Randomized Multicenter Phase II Trial of

✍ Bouche, O. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 357 KB